Literature DB >> 27592208

Priority rules as solutions to conflicting health care rights.

Anna-Karin Andersson1, Frode Lindemark2, Kjell Arne Johansson2,3.   

Abstract

Recent health legislation in Norway significantly increases access to specialist care within a legally binding time frame. The paper describes the contents of the new legislation and introduces some of the challenges with proliferations of rights to health care. The paper describes some of the challenges associated with the proliferation of legal rights to health care. It explains the benefits of assessing the new law in the light of a rights framework. It then analyses the problematic aspects of establishing additional priority rules as solutions to rights conflicts. It then defends adequacy criteria for acceptable priority rules when such rules are unavoidable. It finally defends our proposed method and explores concrete applications.

Keywords:  Health law; Prioritization; Public health; Rights

Mesh:

Year:  2017        PMID: 27592208     DOI: 10.1007/s11019-016-9728-z

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  6 in total

1.  Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers.

Authors:  Norman Daniels; James Sabin
Journal:  Philos Public Aff       Date:  1997

2.  Challenges for principles of need in health care.

Authors:  Niklas Juth
Journal:  Health Care Anal       Date:  2015-03

3.  For the Sake of Justice: Should We Prioritize Rare Diseases?

Authors:  Niklas Juth
Journal:  Health Care Anal       Date:  2017-03

4.  Four unsolved rationing problems. A challenge.

Authors:  N Daniels
Journal:  Hastings Cent Rep       Date:  1994 Jul-Aug       Impact factor: 2.683

Review 5.  Norway: health system review.

Authors:  Ånen Ringard; Anna Sagan; Ingrid Sperre Saunes; Anne Karin Lindahl
Journal:  Health Syst Transit       Date:  2013

6.  Waiting time and socioeconomic status--an individual-level analysis.

Authors:  Karin Monstad; Lars Birger Engesaeter; Birgitte Espehaug
Journal:  Health Econ       Date:  2013-04-23       Impact factor: 3.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.